Navigation Links
Society for Clinical Research Sites Receives Unprecedented Response from Industry Stakeholders to Support Sites by Joining Corporate Partnership Program

ROCKVILLE, Md., June 20, 2013 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is proud to announce the launch of the Global Impact Partnership (GIP) Program.  In just over a month, twelve organizations have joined SCRS' commitment to research site's success.  SCRS Global Impact Partners will provide ongoing development, feedback, and support of industry initiatives designed to include and improve the voice of clinical research sites.  In just seven months since its announcement, SCRS has grown its global membership to represent 1,300 sites in 12 countries.  Within a constantly evolving industry, the Global Impact Partnership Board will work in tandem with SCRS' Leadership Council to identify the work streams most significant to the success of research sites across the world.  Each GIP member will appoint one executive level team member to represent their organization and each organization has made a two year commitment to SCRS. 

The founding GIP industry partners include:
Amgen, AstraZeneca, Eli Lilly, PPD, and Roche

While GIP professional partners include:
Acurian, Aspire IRB, Bio-Optronics, Inc., CFS Clinical, Clinical Site Services, DAC Patient Recruitment Services, and ePharmaSolutions.

More industry GIP members will be announced in the months ahead as are invited.  However, the supplier seats are limited to only 12 organizations.  The first meeting of the GIP Board will be held at this year's Site Solutions Summit in Amelia Island, FL.  The GIP Board will work towards industry changes from operational management, to contracts, to subject retention, and more.  Their collaboration will SCRS continue throughout the year.

SCRS President, Christine Pierre states that "The response we have received from sites joining at such a rapid rate was not a surprise; sites are committed to the industry and to our volunteers.  However, the response our community of sites has received from industry has affirmed that the mission of SCRS to represent the global site community and ensure our voice is heard was long overdue, and they want to be a part of the advancement of SCRS.  It has long been my position that success in the clinical research ecosystem is dependent on the foundation of a strong site base.  Without sites there are no subjects, without subjects there are no new treatments.  Critical success factors are different around the globe, and we look forward to working with our GIPs, Leadership Council and SCRS members to ensure all sites succeed."

About SCRS
SCRS is a trade organization representing global clinical research sites representing 1,300 sites in 12 countries in just seven months of its launch. SCRS' mission is to unify and amplify the voice of the global clinical research site community. SCRS has become an active partner in industry-wide dialogues focused on improving the clinical research enterprise among the many industry initiatives. Sites, as well as companies that sponsor or support the work conducted at the clinical research sites, will also benefit from membership. Visit

SOURCE Society for Clinical Research Sites
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Celebrating 25 Years and Counting: Leukemia and Lymphoma Societys "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients
2. "Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference
3. Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
4. The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
5. The Leukemia & Lymphoma Society Applauds FDAs Approval of Lenalidomide for Patients with Relapsed or Refractory Mantle Cell Lymphoma
6. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
7. Oramed Selected to Present at the 81st European Atherosclerosis Society Congress in Lyon, France, June 2-5, 2013
8. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
9. Genomic Health Announces Results of Ten Studies in Breast, Prostate and Colon Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
10. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
11. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015   VolitionRx Limited (NYSE MKT: ... tests for a broad range of cancer types and other ... Micro Conference, which will be held December 1 - 3 in ... VolitionRx will be David Kratochvil , Chief Financial Officer ... Investor Relations. ® blood-based tests for colorectal ...
(Date:11/30/2015)... Nov. 30, 2015  Precision Image Analysis Inc. ... pleased to announce a dramatic expansion of its ... Building on its ISO-9001:2008 certification for its Quality ... Core Lab protocols and procedures. This expansion enables ... activities.  Their Core Lab services include design and ...
(Date:11/30/2015)... BOSTON , November 30, 2015 ... medicines directed at up to 10 G protein-coupled receptor ... PFE ) to research and develop potential new medicines ... targets across multiple therapeutic areas. --> Heptares ... development company and wholly-owned subsidiary of Sosei Group Corporation ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... 30, 2015 , ... Holcomb – Kreithen Plastic Surgery ... practices in Florida, is proud to announce that Dr. Joshua Kreithen, one of ... Inc., a Johnson & Johnson Company. , Ethicon is a global medical device ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” ... three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... , ... The successful filing of an Investigational New Drug application (IND) is ... this key industry segment, Regis Technologies has decided to sponsor and participate in an ... EST. , Federal law does not allow new drugs to cross state lines until ...
(Date:11/30/2015)... ... 2015 , ... Vasont Systems, a top component content management ... unites with Syncro Soft’s latest software update, oXygen XML editor Version 17.1. Users ... latest release of oXygen® XML editor and the Vasont® CCMS. , The ...
Breaking Medicine News(10 mins):